ADHD

Article

The Value of an ADHD Diagnosis

A Patient’s Perspective

Sparlon and ADHD: The Power of a 7-Year Old

Rarely has a 7-year old with a rash caused the stock price of a major corporation to gyrate so dramatically.

Daytrana: A Long and Winding Road to Approval

On April 6, 2006, the FDA announced the approval of Daytrana, a transdermal patch version of Ritalin (methylphenidate). While you wouldn’t know it by the gushy promotional copy on Daytrana’s website (www.daytrana.com), the Ritalin patch just barely squeaked through the FDA approval process.